Project Grant HT94252410884
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$500K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,200,000 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, with an effective date of Sep 30, 2023 and ultimate completion date of Sep 29, 2026, will fund research focused on "Prevention and Treatment of Frostbite Infection with Antimicrobial Pharmacokinetic Analysis" to be conducted at the University's...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
This Project Grant from the Defense Health Agency provides $349,939 to the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420) from February 1, 2023 to January 31, 2026. The grant funds research on transfemoral osseointegrated prosthesis limb-load symmetry training. As the program description notes, the Military Medical Research and Development program supports basic, applied, and advanced biomedical research to improve military...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...
The federal Project Grant award of $428,220.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by the University of Colorado-Denver to provide innovative insights into the progression of pulmonary hypertension. The research aims to unravel the role of localized small extracellular vesicles, with the performance period running from Dec 1, 2024 to Nov 30, 2026. This award demonstrates the university's significant...
The University of Colorado-Denver received a $1,260,839 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, which runs from May 1, 2025 to April 30, 2029, supports research to target EHMT1/2 in order to overcome therapy-resistant ovarian cancer. The university, a prominent medical research institution, will conduct advanced biomedical investigations focusing on innovative...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...